Contract Research Organization

The DAVA Contract Research Organization (CRO) provides scientific leadership and relationships with high-performance clinical research sites as well as experience in clinical trial design and execution. DAVA’s CRO helps maximize profitability and enhance drug development with some of the nation’s leading pharmaceutical and biotechnology companies. We specialize in the management of early stage and proof-of-concept trials, guiding the entire study from beginning to end. We also provide disease-specific expertise by a DAVA medical oncologist.

The DAVA CRO takes responsibility for clinical trials from beginning to end. This begins with optimizing protocol development, site selection, site contracts, data management, and medical monitoring; then it ends with site close-outs and data reconciliation. The CRO team manages trial enrollment, clinical monitoring, safety surveillance, site payments, and regulatory services throughout the trial. The medical oncology team provides sponsors with support in medical writing, which includes protocol and CRT development, recruitment of patients, monitoring, and in-depth clinical discussions with other oncologist who are key players in helping with accrual to these trials.

The DAVA CRO provides a high level of quality and commitment to each project with its goal to enhance cancer research through expert medical support.